These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 36939908

  • 1. The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease.
    Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K, Zucca FA, Zecca L, Youdim M, Wulf M, Riederer P, Dijkstra JM.
    J Neural Transm (Vienna); 2023 May; 130(5):611-625. PubMed ID: 36939908
    [Abstract] [Full Text] [Related]

  • 2. Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.
    Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K.
    Int J Mol Sci; 2022 Apr 10; 23(8):. PubMed ID: 35456994
    [Abstract] [Full Text] [Related]

  • 3. Catecholamines and Parkinson's disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview.
    Nagatsu T.
    J Neural Transm (Vienna); 2024 Jun 10; 131(6):617-630. PubMed ID: 37638996
    [Abstract] [Full Text] [Related]

  • 4. Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus.
    Wakamatsu K, Tabuchi K, Ojika M, Zucca FA, Zecca L, Ito S.
    J Neurochem; 2015 Nov 10; 135(4):768-76. PubMed ID: 26156066
    [Abstract] [Full Text] [Related]

  • 5. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease.
    Farrand AQ, Helke KL, Gregory RA, Gooz M, Hinson VK, Boger HA.
    Brain Stimul; 2017 Nov 10; 10(6):1045-1054. PubMed ID: 28918943
    [Abstract] [Full Text] [Related]

  • 6. Riddles in the dark: Decoding the relationship between neuromelanin and neurodegeneration in locus coeruleus neurons.
    Iannitelli AF, Weinshenker D.
    Neurosci Biobehav Rev; 2023 Sep 10; 152():105287. PubMed ID: 37327835
    [Abstract] [Full Text] [Related]

  • 7. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, Fauler M, Hetzel A, Watanabe M, Lujan R, Malenka RC, Striessnig J, Liss B.
    Brain; 2014 Aug 10; 137(Pt 8):2287-302. PubMed ID: 24934288
    [Abstract] [Full Text] [Related]

  • 8. [Neuromelanin in neurons of substantia nigra lacking tyrosine hydroxylase].
    Grigor'ev IP, Sukhorukova EG, Kolos EA, Korzhevskiĭ DE.
    Morfologiia; 2012 Aug 10; 141(2):65-7. PubMed ID: 22913142
    [Abstract] [Full Text] [Related]

  • 9. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L, Wilms H, Geick S, Claasen JH, Brandenburg LO, Holzknecht C, Panizza ML, Zucca FA, Deuschl G, Sievers J, Lucius R.
    Acta Neuropathol; 2008 Jul 10; 116(1):47-55. PubMed ID: 18343932
    [Abstract] [Full Text] [Related]

  • 10. DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease.
    Cai W, Wakamatsu K, Zucca FA, Wang Q, Yang K, Mohamadzadehonarvar N, Srivastava P, Tanaka H, Holly G, Casella L, Ito S, Zecca L, Chen X.
    Prog Neurobiol; 2023 Apr 10; 223():102414. PubMed ID: 36746222
    [Abstract] [Full Text] [Related]

  • 11. Neuromelanin of the human substantia nigra: an update.
    Zucca FA, Basso E, Cupaioli FA, Ferrari E, Sulzer D, Casella L, Zecca L.
    Neurotox Res; 2014 Jan 10; 25(1):13-23. PubMed ID: 24155156
    [Abstract] [Full Text] [Related]

  • 12. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X, Yang HA, Wang XN, Du YF.
    Genet Mol Res; 2016 May 09; 15(2):. PubMed ID: 27173342
    [Abstract] [Full Text] [Related]

  • 13. Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Krainc T, Monje MHG, Kinsinger M, Bustos BI, Lubbe SJ.
    Mov Disord; 2023 Feb 09; 38(2):185-195. PubMed ID: 36350228
    [Abstract] [Full Text] [Related]

  • 14. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL, Nelson O, Yazdani U, Pasbakhsh P, German DC.
    J Comp Neurol; 2004 May 17; 473(1):97-106. PubMed ID: 15067721
    [Abstract] [Full Text] [Related]

  • 15. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.
    Zucca FA, Segura-Aguilar J, Ferrari E, Muñoz P, Paris I, Sulzer D, Sarna T, Casella L, Zecca L.
    Prog Neurobiol; 2017 Aug 17; 155():96-119. PubMed ID: 26455458
    [Abstract] [Full Text] [Related]

  • 16. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S, Pita Lobo P, Neutel D, Correia Guedes L, Coelho M, Rosa MM, Ferreira J, Abreu D, Gonçalves N, Morgado C, Nunes RG, Campos J, Ferreira JJ.
    Eur J Neurol; 2015 Mar 17; 22(3):540-6. PubMed ID: 25534480
    [Abstract] [Full Text] [Related]

  • 17. The enigma of neuromelanin in Parkinson's disease substantia nigra.
    Youdim MB, Ben-Shachar D, Riederer P.
    J Neural Transm Suppl; 1994 Mar 17; 43():113-22. PubMed ID: 7884393
    [Abstract] [Full Text] [Related]

  • 18. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis.
    Carballo-Carbajal I, Laguna A, Romero-Giménez J, Cuadros T, Bové J, Martinez-Vicente M, Parent A, Gonzalez-Sepulveda M, Peñuelas N, Torra A, Rodríguez-Galván B, Ballabio A, Hasegawa T, Bortolozzi A, Gelpi E, Vila M.
    Nat Commun; 2019 Mar 07; 10(1):973. PubMed ID: 30846695
    [Abstract] [Full Text] [Related]

  • 19. Expression of tyrosine hydroxylase isoforms and phosphorylation at serine 40 in the human nigrostriatal system in Parkinson's disease.
    Shehadeh J, Double KL, Murphy KE, Bobrovskaya L, Reyes S, Dunkley PR, Halliday GM, Dickson PW.
    Neurobiol Dis; 2019 Oct 07; 130():104524. PubMed ID: 31276794
    [Abstract] [Full Text] [Related]

  • 20. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E, Santin MD, Valabrègue R, Mangone G, Gaurav R, Pyatigorskaya N, Hutchison M, Yahia-Cherif L, Villain N, Habert MO, Arnulf I, Leu-Semenescu S, Dodet P, Vila M, Corvol JC, Vidailhet M, Lehéricy S.
    Brain; 2021 Nov 29; 144(10):3114-3125. PubMed ID: 33978742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.